PHENPath.com – Empowering Patients
Drawing on his experience as a prostate cancer survivor, PHEN President Thomas A. Farrington explains that newly diagnosed prostate cancer patients often lack knowledge about the right treatment pathways for their needs. To solve this serious challenge, Mr. Farrington obtained sponsorship from Amgen to build PHENPath.com and educate men on prostate cancer treatment pathways. Whether a patient is recently diagnosed or faces a recurrence of prostate cancer, PHENPath.com provides much-needed information based on personalized risk levels.
“A lack of knowledge is a major problem with men who are diagnosed with prostate cancer,” stated PHEN Founder and President Thomas A. Farrington. “We decided to address this issue with a treatment pathway tool for prostate cancer patients.”
